Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?

Overview of attention for article published in Journal of Global Oncology, June 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 2 blogs
policy: 1 policy source

twitter: 12 X users

Readers on

mendeley: 56 Mendeley

So far, Altmetric has seen 18 X posts from 12 X users, with an upper bound of 123,649 followers.

RT @JGO_ASCO: Compulsory licenses: Certainly controversial, but can they help increase access to cancer drugs? https://t.co/Ql9HD4EKzA #JGO…

Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications? https://t.co/sn9O1WLOSd

RT @JGO_ASCO: Compulsory licenses: Certainly controversial, but can they help increase access to cancer drugs? https://t.co/Ql9HD4EKzA #JGO…

RT @GlopesMd: Compulsory licensing for cancer medications: examples, benefits and pitfalls @JGO_ASCO @ASCO https://t.co/QEIfzHLhUq

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 14 additional X posts.